In Depth

DCT Tracker: Tracking how sponsors fare at conducting DCTs

Why are haemophilia gene therapies so expensive?

Non-viral vectors could alleviate gene therapy capacity crunch

Q&A: ‘Trial failure due to recruitment is a thing of the past thanks to AI’